|
시장보고서
상품코드
2087821
재택 의료 시장 : 서비스 유형별, 제품 유형, 제공 형태, 환자 상태, 최종 사용자별 - 세계 시장 예측(2026-2032년)Home Healthcare Market by Service Type, Product Type, Delivery Mode, Patient Condition, End User - Global Forecast 2026-2032 |
||||||
360iResearch
재택 의료 시장은 2032년까지 연평균 복합 성장률(CAGR) 8.87%로 성장해 6,390억 7,000만 달러 규모로 확대될 것으로 예측됩니다.
| 주요 시장 통계 | |
|---|---|
| 기준 연도(2025년) | 3,523억 9,000만 달러 |
| 추정 연도(2026년) | 3,829억 5,000만 달러 |
| 예측 연도(2032년) | 6,390억 7,000만 달러 |
| CAGR(%) | 8.87% |
재택 의료는 급성기 이후의 지원 서비스에서 현대 의료 제공의 핵심 축으로 점차 전환되고 있습니다. 이 분야에는 전문 간호, 재활 치료, 개인 간호, 재택 정맥 주사 요법, 호스피스 및 완화 의료, 내구성 의료장비, 원격 의료, 원격 환자 모니터링 등이 포함됩니다. 수요를 견인하고 있는 요인은 고령화, 만성 질환 유병률 증가, 병원의 수용 능력 부족, 저비용 의료 환경에 대한 보험사의 인센티브, 그리고 집에서 돌봄을 받고 싶어 하는 소비자들의 의향입니다.
인구 동향에 관한 증거는 명백합니다. 세계보건기구(WHO)의 보고에 따르면, 2030년까지 전 세계 인구의 6명 중 1명이 60세 이상이 될 것으로 예상되며, 한편 유엔은 2050년까지 전 세계 65세 이상 인구가 2배 이상 증가해 약 16억 명에 달할 것으로 전망하고 있습니다. 이러한 변화에 따라, 재택에서의 만성 질환 관리, 낙상 예방, 복약 순응도 관리, 상처 관리, 호흡 지원, 이동 지원 및 돌봄 제공업체를 위한 서비스의 필요성이 높아지고 있습니다.
의료 제공업체, 보험사, 의료기기 제조업체, 기술 공급업체, 그리고 투자자들에게 있어 재택 의료 시장은 임상적 품질, 인재 확보, 보상 제도와의整合性, 디지털화 추진, 상호운용성에 의해 점점 더 정의되고 있습니다. 증거에 기반한 치료 경로와 확장성이 있는 인력 배치 모델, 그리고 안전한 의료 기술을 결합한 조직이야말로, 치료 총비용을 억제하면서도 치료 성과를 향상시킬 수 있는 최상의 위치에 있다고 할 수 있습니다.
재택 의료 현장에서 일어나고 있는 혁신적인 변화
재택 의료의 양상은 시설 중심의 치료에서 가정, 지역사회 및 가상 채널을 통해 제공되는 장기적인 환자 중심의 돌봄으로 전환되면서 재편되고 있습니다. 병원과 의료 시스템은 피할 수 있는 재입원을 줄이고 병상 가동률을 높이기 위해 ‘재택 병원(Hospital-at-Home)’, 퇴원 후 모니터링, 그리고 전환기 관리 프로그램을 확대되고 있습니다. 보험사 역시 예방, 협력적인 만성 질환 관리, 그리고 측정 가능한 환자 결과를 평가하는 가치 기반 진료 모델을 지원하고 있습니다.
재택 의료 분야에서 인공지능이 미치는 누적 영향
인공지능(AI)은 위험도 계층화, 치료 조정, 임상 기록, 업무 배분, 인력 배치, 원격 모니터링을 통한 분류, 청구 심사 및 환자 참여를 개선함으로써 재택 의료의 전체 밸류체인에 누적 영향을 미치고 있습니다. AI를 활용한 분석을 통해 입원, 복약 불이행, 욕창, 낙상 또는 병세 악화 위험이 높은 환자를 파악할 수 있게 됨으로써, 임상팀은 더 조기에 개입하고 제한된 자원을 보다 효과적으로 배분할 수 있게 됩니다.
전 세계 재택 의료에 대한 주요 지역별 인사이트
북미는 확립된 환급 제도, 메디케어 및 메디케이드 프로그램, 민간 보험의 보장 범위, 원격 환자 모니터링의 도입, 그리고 고령층의 강력한 수요에 힘입어 여전히 가장 성숙한 재택 의료 시장 중 하나입니다. 미국 인구조사국의 보고서에 따르면, 2050년까지 고령자가 전체 인구에서 차지하는 비중이 크게 증가할 것으로 예상되며, 이에 따라 전문적인 재택 의료, 개인 간호, 재택 1차 진료 및 만성 질환 관리에 대한 수요가 더욱 높아질 것으로 전망됩니다. 캐나다 역시 병원의 부담을 줄이고 지역 내 고령화 문제를 지원하기 위해 재택 및 지역사회 돌봄을 추진하고 있습니다.
재택 의료 확대에 관한 주요 그룹별 인사이트
지역 그룹 중에서는 유럽연합(EU)이 데이터 보호, 디지털 헬스 정책, 의료기기 규제 및 장기 요양 기준을 통해 재택 의료에 큰 영향력을 행사하고 있습니다. 통합 돌봄, 건강한 노화, 안전한 의료 데이터 교환에 관한 EU의 우선 과제는 엄격한 개인정보 보호, 안전성, 상호운용성 요건을 유지하면서 재택 돌봄 제공 체계를 현대화하도록 사업자들을 독려하고 있습니다.
재택 의료와 관련된 주요 국가의 동향
미국은 규모와 혁신 면에서 선도적인 위치를 차지하고 있으며, 메디케어 인증을 받은 재택 의료, 개인 간호, 호스피스, 재택 정맥 주사 요법, 원격 환자 모니터링에 대한 수요가 활발합니다. 캐나다는 고령화 사회를 뒷받침하기 위한 재택 및 지역사회 돌봄 체계 구축에 주력하고 있는 반면, 멕시코에서는 민간 사업자, 도시 지역의 의료 수요, 만성 질환 관리에 대한 필요성을 배경으로 성장이 나타나고 있습니다. 브라질은 방대한 인구, 민간 의료보험의 보급, 재택 간호에 대한 수용도 증가에 힘입어 라틴아메리카에서 가장 주목받는 시장이 되고 있습니다.
재택 의료 리더를 위한 실천적 제안
업계 리더는 단일 환자 기록과 측정 가능한 성과를 중심으로, 병원, 1차 진료 기관, 전문의, 약국, 간병인, 보험사를 연결하는 통합 진료 모델을 우선시해야 합니다. 재입원율 감소, 복약 순응도 향상, 기능 회복 개선, 그리고 높은 환자 만족도를 입증할 수 있는 재택 의료 기관은 가치 기반 보상 체계 하에서 더 유리한 입지를 확보할 수 있을 것입니다.
조사 방법
본 요약본은 헬스케어 시장 정보의 모범 사례에 따라 체계적인 2차 조사 방식을 활용하여 작성되었습니다. 참고로 삼은 정보 출처에는 공중보건 기관, 각국 통계청, 보험 지급 기관, 규제 기관, 동료 심사를 거친 문헌, 보험사의 정책 문서, 디지털 헬스 관련 지침, 그리고 세계보건기구(WHO), 유엔, 세계은행, OECD, 각국 보건부 등 공인된 국제 기구가 포함됩니다.
결론
재택 의료는 회복력이 뛰어나며, 환자 중심의 의료 시스템에서 필수적인 요소로 자리 잡고 있습니다. 인구 고령화, 만성 질환 유병률 증가, 병원의 수용 능력에 가해지는 압박, 그리고 재택 간호를 선호하는 소비자의 경향으로 인해 선진국과 신흥 시장 모두에서 지속적인 수요가 발생하고 있습니다. 가장 큰 기회는 상환 제도, 인재 공급 능력, 디지털 인프라, 그리고 임상 거버넌스가 조화를 이루고 있는 지역에서 나타나고 있습니다.
자주 묻는 질문
목차
제1장 서문
제2장 조사 방법
제3장 주요 요약
제4장 시장 개요
제5장 시장 인사이트
제6장 AI의 누적 영향(2026년)
제7장 재택 의료 시장 : 서비스 유형별
제8장 재택 의료 시장 : 제품 유형별
제9장 재택 의료 시장 : 유통 모드별
제10장 재택 의료 시장 : 환자 상태별
제11장 재택 의료 시장 : 최종 사용자별
제12장 재택 의료 시장 : 지역별
제13장 재택 의료 시장 : 그룹별
제14장 재택 의료 시장 : 국가별
제15장 경쟁 구도
제16장 기업 개요
KTH 26.07.21The Home Healthcare Market is projected to grow by USD 639.07 billion at a CAGR of 8.87% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 352.39 billion |
| Estimated Year [2026] | USD 382.95 billion |
| Forecast Year [2032] | USD 639.07 billion |
| CAGR (%) | 8.87% |
Home healthcare is moving from a post-acute support service to a core pillar of modern care delivery. The sector spans skilled nursing, rehabilitation therapy, personal care, home infusion, hospice and palliative support, durable medical equipment, telehealth, and remote patient monitoring. Demand is being driven by aging populations, rising chronic disease prevalence, hospital capacity pressure, payer incentives for lower-cost care settings, and consumer preference to receive care at home.
The demographic evidence is clear. The World Health Organization reports that by 2030, one in six people worldwide will be aged 60 years or older, while the United Nations projects the global population aged 65 and above will more than double to approximately 1.6 billion by 2050. These shifts are increasing the need for home-based chronic care management, fall prevention, medication adherence, wound care, respiratory support, mobility assistance, and caregiver services.
For healthcare providers, payers, medical device manufacturers, technology vendors, and investors, the home healthcare market is increasingly defined by clinical quality, workforce availability, reimbursement alignment, digital enablement, and interoperability. Organizations that combine evidence-based care pathways with scalable staffing models and secure health technology are best positioned to improve outcomes while controlling total cost of care.
Transformative Shifts in the Home Healthcare Landscape
The home healthcare landscape is being reshaped by the shift from facility-centered treatment to longitudinal, patient-centered care delivered across the home, community, and virtual channels. Hospitals and health systems are expanding hospital-at-home, post-discharge monitoring, and transitional care programs to reduce avoidable readmissions and improve bed capacity. Payers are also supporting value-based care models that reward prevention, coordinated chronic disease management, and measurable patient outcomes.
Technology is accelerating this transition. Connected medical devices, remote patient monitoring platforms, electronic visit verification, digital medication management, and interoperable electronic health records are turning the home into a data-rich care environment. At the same time, regulatory scrutiny around patient safety, data privacy, clinical documentation, and workforce credentialing is increasing, making compliance a competitive differentiator.
The most significant constraint remains labor. The World Health Organization projects a global shortfall of 11 million health workers by 2030, with the greatest gaps in low- and lower-middle-income countries, while national workforce agencies continue to report shortages across nursing, personal care, and long-term care occupations. As demand rises, providers are redesigning roles, investing in caregiver training, using scheduling automation, and partnering with community-based organizations to maintain continuity of care.
Cumulative Impact of Artificial Intelligence in Home Healthcare
Artificial intelligence is creating cumulative impact across the home healthcare value chain by improving risk stratification, care coordination, clinical documentation, routing, staffing, remote monitoring triage, claims review, and patient engagement. AI-enabled analytics can help identify patients at elevated risk of hospitalization, medication nonadherence, pressure injuries, falls, or deterioration, allowing clinical teams to intervene earlier and allocate scarce resources more effectively.
In operations, AI can support visit scheduling, workforce matching, revenue cycle management, fraud detection, and documentation quality. In clinical workflows, ambient documentation, decision support, and predictive alerts can reduce administrative burden when deployed with appropriate clinician oversight. These capabilities are particularly valuable in home healthcare, where fragmented data, distributed teams, and variable patient environments create operational complexity.
The impact of AI depends on governance. Health Insurance Portability and Accountability Act requirements in the United States, the European Union General Data Protection Regulation, emerging AI rules, and medical device software oversight require transparent model validation, cybersecurity controls, bias monitoring, human review, and clear accountability. Industry leaders should treat AI as an augmentation layer that strengthens clinical judgment rather than replaces it.
Key Regional Insights Across Global Home Healthcare
North America remains one of the most mature home healthcare markets, supported by established reimbursement structures, Medicare and Medicaid programs, private insurance coverage, remote patient monitoring adoption, and strong demand from older adults. The U.S. Census Bureau has reported that older adults are projected to represent a substantially larger share of the population by 2050, reinforcing demand for skilled home health, personal care, home-based primary care, and chronic disease management. Canada is also advancing home and community care to reduce hospital pressure and support aging in place.
Europe is shaped by universal health systems, long-term care reform, and strong regulatory emphasis on quality, privacy, and workforce standards. The European Commission and national health authorities are promoting digital health infrastructure, cross-border data frameworks, and aging-in-place initiatives, while countries such as Germany, France, Italy, Spain, and the United Kingdom face rising demand for home nursing, rehabilitation, dementia support, and caregiver services as old-age dependency increases.
Asia-Pacific represents a high-opportunity region due to rapid aging in Japan, South Korea, China, Australia, and parts of Southeast Asia, combined with expanding digital health adoption and policy support for community-based eldercare. Latin America is gaining momentum as Brazil and Mexico invest in private healthcare delivery, chronic disease programs, and home-based services for urban populations. The Middle East, particularly the Gulf region, is using health system modernization and national digital health strategies to expand home care, while Africa's opportunity is tied to community health worker networks, mobile health tools, and improved access to essential home-based care in underserved communities.
Key Group Insights for Home Healthcare Expansion
Among regional groups, the European Union has a strong influence on home healthcare through data protection, digital health policy, medical device regulation, and long-term care standards. EU priorities around integrated care, healthy aging, and secure health data exchange are encouraging providers to modernize home-based care delivery while maintaining strict privacy, safety, and interoperability requirements.
The G7 markets are characterized by advanced healthcare infrastructure, aging populations, high chronic disease burden, and growing interest in hospital-at-home and value-based care models. BRICS countries represent scale-driven opportunity, with China, India, and Brazil showing strong demand potential as middle-class populations expand, digital health adoption rises, and health systems pursue more cost-effective care outside hospitals.
ASEAN markets are diverse but increasingly important as governments expand universal health coverage, strengthen primary care, and adopt mobile health tools. GCC countries are investing in premium home care, digital health platforms, and chronic disease management as part of broader healthcare transformation agendas. NATO countries overlap significantly with high-income healthcare systems where resilience, medical supply continuity, cybersecurity, and emergency preparedness are increasingly relevant to home-based care infrastructure and continuity of services.
Key Country Insights in Home Healthcare
The United States leads in scale and innovation, with strong demand for Medicare-certified home health, personal care, hospice, home infusion, and remote patient monitoring. Canada is focused on home and community care capacity to support aging populations, while Mexico is seeing growth through private providers, urban healthcare demand, and chronic disease management needs. Brazil is the most prominent Latin American market, supported by a large population, private health insurance participation, and increasing acceptance of home-based care.
In Europe, the United Kingdom is prioritizing community-based care and virtual wards to reduce pressure on public hospitals. Germany's long-term care insurance system supports formal home care services, while France is expanding coordinated care for older adults and chronic patients. Italy and Spain face some of the world's highest aging pressures, creating sustained demand for home nursing, rehabilitation, and family caregiver support. Russia's market is influenced by demographic needs, regional access gaps, and demand for home medical services in major urban centers.
In Asia-Pacific, China's aging population and policy focus on eldercare are creating large-scale demand for home and community services. India offers long-term growth through home nursing, diagnostics, physiotherapy, and chronic care in major cities. Japan is one of the most advanced aging societies, with strong need for long-term home care, assistive technologies, and caregiver productivity tools. Australia continues to expand consumer-directed home care, and South Korea is investing in eldercare, digital health, and community-based support.
Actionable Recommendations for Home Healthcare Leaders
Industry leaders should prioritize integrated care models that connect hospitals, primary care, specialists, pharmacies, caregivers, and payers around a single patient record and measurable outcomes. Home healthcare organizations that can demonstrate lower readmissions, improved medication adherence, better functional recovery, and high patient satisfaction will be better positioned in value-based reimbursement environments.
Providers should invest in workforce resilience by improving caregiver compensation strategies, training, safety protocols, career pathways, and technology-enabled scheduling. Partnerships with nursing schools, community colleges, immigration pathways where applicable, and family caregiver education programs can help reduce staffing constraints while improving quality.
Technology investments should focus on interoperability, cybersecurity, remote patient monitoring, AI-assisted triage, and documentation automation. Leaders should avoid fragmented point solutions and instead build scalable platforms that integrate with electronic health records, payer systems, and clinical workflows. A disciplined approach to compliance, privacy, and outcomes measurement will be essential for sustainable growth.
Research Methodology
This executive summary is developed using a structured secondary research approach aligned with healthcare market intelligence best practices. Sources considered include public health agencies, national statistics offices, reimbursement authorities, regulatory bodies, peer-reviewed literature, payer policy documents, digital health guidance, and recognized international organizations such as the World Health Organization, United Nations, World Bank, OECD, and government health departments.
The analysis evaluates demand drivers, demographic indicators, chronic disease trends, care delivery models, reimbursement dynamics, technology adoption, workforce constraints, and regional policy developments. Market interpretation is based on triangulation across multiple credible sources rather than single-point estimates, with emphasis on data-backed trends that directly affect home healthcare adoption and strategic planning.
Qualitative assessment is applied to compare regional maturity, country-level opportunity, group-level policy influence, and the operational impact of artificial intelligence. The methodology prioritizes verified evidence, practical business relevance, and industry terminology for decision-makers evaluating the global home healthcare market.
Conclusion
Home healthcare is becoming an essential component of resilient, patient-centered health systems. Aging demographics, chronic disease prevalence, hospital capacity pressure, and consumer preference for care at home are creating durable demand across both developed and emerging markets. The strongest opportunities are emerging where reimbursement, workforce capacity, digital infrastructure, and clinical governance align.
Artificial intelligence, remote monitoring, and interoperable platforms will increasingly define competitive advantage, but technology must be implemented with strong privacy, safety, and equity safeguards. Providers that combine compassionate care delivery with data-driven operations will be best positioned to scale.
The future of home healthcare will be measured not only by expansion, but by outcomes: fewer avoidable hospitalizations, safer aging in place, better chronic disease control, improved caregiver support, and lower total cost of care. Organizations that act now can lead the transition from episodic home services to integrated home-based healthcare.
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Definition
- 1.3. Market Segmentation & Coverage
- 1.4. Years Considered for the Study
- 1.5. Currency Considered for the Study
- 1.6. Language Considered for the Study
- 1.7. Key Stakeholders
2. Research Methodology
- 2.1. Introduction
- 2.2. Research Design
- 2.2.1. Primary Research
- 2.2.2. Secondary Research
- 2.3. Research Framework
- 2.3.1. Qualitative Analysis
- 2.3.2. Quantitative Analysis
- 2.4. Market Size Estimation
- 2.4.1. Top-Down Approach
- 2.4.2. Bottom-Up Approach
- 2.5. Data Triangulation
- 2.6. Research Outcomes
- 2.7. Research Assumptions
- 2.8. Research Limitations
3. Executive Summary
- 3.1. Introduction
- 3.2. CXO Perspective
- 3.3. Market Size & Growth Trends
- 3.4. Market Share Analysis, 2025
- 3.5. FPNV Positioning Matrix, 2025
- 3.6. New Revenue Opportunities
- 3.7. Next-Generation Business Models
- 3.8. Industry Roadmap
4. Market Overview
- 4.1. Introduction
- 4.2. Industry Ecosystem & Value Chain Analysis
- 4.2.1. Supply-Side Analysis
- 4.2.2. Demand-Side Analysis
- 4.2.3. Stakeholder Analysis
- 4.3. Market Dynamics
- 4.3.1. Key Drivers
- 4.3.2. Key Restraints
- 4.3.3. Key Opportunities
- 4.3.4. Key Challenges
- 4.4. Porter's Five Forces Analysis
- 4.5. PESTLE Analysis
- 4.6. Market Outlook
- 4.6.1. Near-Term Market Outlook (0-2 Years)
- 4.6.2. Medium-Term Market Outlook (3-5 Years)
- 4.6.3. Long-Term Market Outlook (5-10 Years)
- 4.7. Go-to-Market Strategy
5. Market Insights
- 5.1. Consumer Insights & End-User Perspective
- 5.2. Consumer Experience Benchmarking
- 5.3. Opportunity Mapping
- 5.4. Distribution Channel Analysis
- 5.5. Pricing Trend Analysis
- 5.6. Regulatory Compliance & Standards Framework
- 5.7. ESG & Sustainability Analysis
- 5.8. Disruption & Risk Scenarios
- 5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Home Healthcare Market, by Service Type
- 7.1. Home Health Aides
- 7.2. Hospice & Palliative Care
- 7.3. Skilled Nursing
- 7.3.1. Chronic Disease Management
- 7.3.2. Medication Management
- 7.3.3. Wound Care
- 7.4. Therapy Services
- 7.4.1. Cardiopulmonary Therapy
- 7.4.2. Occupational Therapy
- 7.4.3. Physical Therapy
- 7.4.4. Speech-Language Therapy
8. Home Healthcare Market, by Product Type
- 8.1. Diagnostic & Monitoring Devices
- 8.1.1. Blood Glucose Monitoring
- 8.1.2. Blood Pressure Monitors
- 8.1.3. Pulse Oximeters
- 8.1.4. Thermometers
- 8.1.5. Wearables & Biosensors
- 8.2. Disposables & Consumables
- 8.2.1. Incontinence Products
- 8.2.2. Ostomy Supplies
- 8.2.3. Syringes & Lancets
- 8.2.4. Wound Care Supplies
- 8.3. Home Care Software & Platforms
- 8.3.1. Analytics & Quality Reporting
- 8.3.2. Clinical Documentation
- 8.3.3. Scheduling & Workforce Management
- 8.4. Mobility & Daily Living Aids
- 8.4.1. Bathroom Safety
- 8.4.2. Lift & Transfer Aids
- 8.4.3. Walkers & Rollators
- 8.4.4. Wheelchairs
- 8.5. Therapeutic Equipment
- 8.5.1. Dialysis Equipment
- 8.5.2. Infusion Pumps
- 8.5.3. Insulin Delivery
- 8.5.4. Nebulizers & Inhalation Therapy
- 8.5.5. Oxygen Therapy
- 8.5.5.1. Portable Concentrators
- 8.5.5.2. Stationary Concentrators
9. Home Healthcare Market, by Delivery Mode
- 9.1. In-Person
- 9.2. Remote Monitoring
10. Home Healthcare Market, by Patient Condition
- 10.1. Behavioral & Mental Health
- 10.2. Cardiovascular Care
- 10.3. Diabetes Care
- 10.4. Maternal & Newborn
- 10.5. Musculoskeletal Care
- 10.5.1. Arthritis Management
- 10.5.2. Fracture Rehabilitation
- 10.6. Palliative & End-Of-Life
- 10.7. Respiratory Care
11. Home Healthcare Market, by End User
- 11.1. Adults
- 11.2. Geriatrics
- 11.3. Pediatrics
12. Home Healthcare Market, by Region
- 12.1. Asia-Pacific
- 12.2. North America
- 12.3. Latin America
- 12.4. Europe
- 12.5. Middle East
- 12.6. Africa
13. Home Healthcare Market, by Group
- 13.1. ASEAN
- 13.2. GCC
- 13.3. European Union
- 13.4. BRICS
- 13.5. G7
- 13.6. NATO
14. Home Healthcare Market, by Country
- 14.1. United States
- 14.2. Canada
- 14.3. Mexico
- 14.4. Brazil
- 14.5. United Kingdom
- 14.6. Germany
- 14.7. France
- 14.8. Russia
- 14.9. Italy
- 14.10. Spain
- 14.11. China
- 14.12. India
- 14.13. Japan
- 14.14. Australia
- 14.15. South Korea
15. Competitive Landscape
- 15.1. Market Concentration Analysis, 2025
- 15.1.1. Concentration Ratio (CR)
- 15.1.2. Herfindahl Hirschman Index (HHI)
- 15.2. Recent Developments & Impact Analysis, 2025
- 15.3. Product Portfolio Analysis, 2025
- 15.4. Benchmarking Analysis, 2025
16. Company Profiles
- 16.1. Fresenius SE & Co. KGaA
- 16.2. Koninklijke Philips N.V.
- 16.3. Abbott Laboratories
- 16.4. Resmed Corp.
- 16.5. Medtronic plc
- 16.6. Humana, Inc.
- 16.7. AdaptHealth, LLC
- 16.8. Option Care Health Inc.
- 16.9. Amedisys, Inc.
- 16.10. Owens & Minor
- 16.11. Linde plc
- 16.12. 3M Company
- 16.13. A&D Company, Limited
- 16.14. AccentCare, Inc.
- 16.15. Addus HomeCare Corporation
- 16.16. BAYADA Home Health Care
- 16.17. BrightSpring Health Services
- 16.18. Cardinal Health Inc
- 16.19. Coloplast A/S
- 16.20. Convatec Group PLC
- 16.21. Drive DeVilbiss Healthcare
- 16.22. Encompass Health Corporation
- 16.23. F. Hoffmann-La Roche Ltd
- 16.24. GE HealthCare Technologies Inc
- 16.25. Interim HealthCare Inc.
- 16.26. Invacare Corporation
- 16.27. LHC Group, Inc.
- 16.28. OMRON Healthcare Co. Ltd
- 16.29. Pinnacle Home Care
- 16.30. Sunrise Medical LLC
